- ROUNDTABLE: Pharmacy’s future in sync with technology
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Study from NCPA sheds new light on med synchronization programs
- EXPERT BLOG: Provider status for pharmacists — one way or another
DEERFIELD, Ill. — Walgreens recently presented the research on how community pharmacy programs, as well as new adherence models and metrics, can help drive better medication adherence. The research, presented at the World Congress Summit in Philadelphia last Friday, demonstrates the company’s success in improving patient medication adherence by developing an infrastructure that tracks patient-level adherence and uses predictive modeling along with risk stratification to identify patient patterns.
“Medication nonadherence is one of the greatest and most costly barriers in treating illness today,” noted Kristi Rudkin, Walgreens senior director product development. “By developing programs and services that can help reduce these barriers, and examining ways to drive cost savings and improved health outcomes through better adherence, we can help more people get, stay and live well.”
Walgreens also can help lower general healthcare costs for payers. New-to-therapy patients often face adherence challenges while trying to learn a new medication regimen. A retrospective cohort study assessing the impact of pharmacist-led, face-to-face counseling in new-to-therapy statin patients found that compared to usual pharmacy care, those patients receiving face-to-face counseling had 7.2% higher adherence.
Forgetfulness also can be a contributor to nonadherence. In a pilot program, automated refill reminders significantly improved patient adherence to medications used to treat chronic conditions. Patients who received automated Interactive Voice Responses telephonic reminders had a significantly higher medication possession ratio compared with patients who did not receive reminders. Additionally, the persistence for the intervention was nearly eight days longer than that of the control group.
“Helping patients improve their medication adherence is a challenge for providers, payers and many others within the healthcare system,” commented Michael Taitel, Walgreens senior director of clinical outcomes and analytic services. “We’ve demonstrated the effectiveness of several programs and initiatives — including our new to therapy program, automated refill reminder calls. Integrating predictive modeling and risk stratification will help us be even more effective at driving better adherence and ultimately, better health outcomes.”
Rudkin and Taitel discussed the research findings along with product-specific interventions focused on empowering patients to better self-manage their condition. Medication nonadherence is estimated to cost the U.S. healthcare system $300 billion dollars per year. The World Congress Summit to Improve Adherence and Enhance Patient Engagement gathered medical experts to address ways in which effective interventions and coordination can improve adherence rates and drive better patient outcomes. The summit took place March 14-15 in Philadelphia.